Ampersand Health and UCB partner in new arthritis initiative
Companies will support a study which provides vital information on arthritis for patient-supporting HCPs
Read More
Tag: Ampersand
- Lario Therapeutics awarded $2.4m to advance calcium channel platform
- Mikrobiomik secures approval for gut‑microbiota therapy for C difficile infection
- Exdensur approved in EU for severe asthma and CRSwNP
- Axol Bioscience acquires Newcells Biotech ophthalmology unit
- Nuclera and leadXpro partner to accelerate structure‑based drug design
